Accutane Lawsuits Continue to Pile Up

New Accutane lawsuits are continuing to pour into a mass tort in New Jersey state court, as more and more plaintiffs file claims alleging that the acne drug caused them to develop inflammatory bowel disease (IBD). 

Well over 400 lawsuits over Accutane have been filed in just the past two months according to the most recent case list provided by the New Jersey courts. The influx of cases brings the total number of New Jersey state court lawsuits over the acne drug to nearly 1,600. All were filed by plaintiffs who claim that Roche failed to adequately warn users about potential Accutane side effects, including the risk of IBD, ulcerative colitis and Crohn’s disease.

Accutane (isotretinoin) has been used by more than 16 million people worldwide since it was first introduced in the early 1980s as a treatment for severe acne. Although Roche discontinued the drug in the United States in June 2009 due to the cost of litigation, a number of generic versions remain available under a number of names, such as Claravis, Sotret, Amnesteem and generic isotretinoin.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

Although Accutane suits against Roche go back as far as 2003, a number of cases have been filed recently following rulings by the state’s high court which affirmed that the Accutane statute of limitations in each case should be based on when plaintiffs discovered there could be a connection between the drug and their bowel disorder. Roche had argued that the statute of limitations should be based on when they placed IBD warnings on the drug’s label. However, many former users never learned about the connection between their bowel problems and Accutane until recent news coverage of Accutane trials and television advertisements by Accutane lawyers.

Roche has lost all six Accutane bowel disease trials that have reached a jury so far, with many resulting in multi-million dollar awards.

1 Comments

  • ValerieNovember 13, 2010 at 4:46 pm

    I took the Accutane in 1994 and again in 1999 for three months each time and then discontinued because the side effects were too much for me to take. About a year ago I started experiencing increased problems with my stomach and bowels. I have all the symptoms of intestional problems but need a colonoscopy to diagnose what is actually wrong and can't afford the testing. I'm told that the class [Show More]I took the Accutane in 1994 and again in 1999 for three months each time and then discontinued because the side effects were too much for me to take. About a year ago I started experiencing increased problems with my stomach and bowels. I have all the symptoms of intestional problems but need a colonoscopy to diagnose what is actually wrong and can't afford the testing. I'm told that the class action is only for those that have a diagnosis within 5 years of taking the drug and I didn't have symptoms for 10 years AND I haven't actually been diagnosed YET. I understand there are different classes for this type of suit so I'm trying to find out if there is any class for somebody like me that didn't have any symptoms for 10 years. Maybe it's because I didn't take the full cycle that it took longer to manifest?

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Depo-Provera Brain Tumor Warnings Added to Drug Label in Europe, But Not In U.S.
Depo-Provera Brain Tumor Warnings Added to Drug Label in Europe, But Not In U.S. (Posted yesterday)

A recently filed Depo-Provera lawsuit questions why Pfizer updated the drug label in Europe, to warn about the risk of meningioma brain tumors, but failed to provide the same Depo-Provera warnings to U.S. consumers and doctors.

Hair Relaxer Lawsuit Status Conference To Be Held With MDL Judge This Week
Hair Relaxer Lawsuit Status Conference To Be Held With MDL Judge This Week (Posted 3 days ago)

U.S. District Judge presiding over all federal hair relaxer lawsuits will meet with lawyers involved in the litigation on Thursday, to discuss the status of the claims and when to move forward with bellwether cases.